RxSight, Inc. Common Stock RXST
$6.54
-6.97%
at last close
Market Cap$292.40 million
P/E Ratio—
Div Yield—
Volume605.4K
52-Week Range
$4.48$13.22
Analyst Ratings
- Consensus
- Hold — 1 Buy · 5 Hold · 2 Sell (8 analysts)
- Avg. Price Target
- $8.60 (+31.5% upside)
Key Stats
- Today's Range
- $6.48 – $7.11
- 50-Day Range
- $4.72 – $7.44
- 52-Week Range
- $4.48 – $13.22
- Volume
- 605K shs
- Average Volume
- 879K shs
- Market Cap
- $292.40 million
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 2.42%
- Days to Cover
- 4.14
About RxSight, Inc. Common Stock
RxSight Inc is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture, and sale of light adjustable lenses and related capital equipment.
Related Stocks
Compare head-to-head: RXST vs NVDA·RXST vs AAPL·RXST vs GOOGL·RXST vs GOOG
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.